177 results
Page 4 of 9
6-K
EX-99.1
rzgucccuupba op69
8 Mar 22
Enlivex Announces Issuance of Israeli Patent Covering Allocetra Derived from Pooled Donor Cells
8:03am
6-K
EX-99.1
jcnzt ocdkn
22 Feb 22
Enlivex Strengthens Management Team with the Appointment of Biotech Industry Veteran Einat Galamidi, M.D., as Vice President, Medical
8:01am
6-K
EX-99.1
qty efilg9tkuj1l
13 Dec 21
Enlivex Receives Regulatory Authorization to Expand its Phase IIb Trial Evaluating Allocetra in Severe and Critical COVID-19 Patients into Greece
8:00am
6-K
EX-99.1
0uq29
7 Dec 21
Enlivex Receives Regulatory Authorization to Expand its Phase II Sepsis Trial into Greece
8:01am
6-K
EX-99.1
ezgbo4o n8r9ye
6 Dec 21
Enlivex Receives Notice of Allowance for U.S. Patent Application
8:00am
6-K
EX-99.1
u7p5z1
22 Nov 21
Enlivex Announces Third Quarter 2021 Financial Results and Provides a Business Update
8:00am
6-K
EX-99.2
nv8qj8b kda95pjv
19 Nov 21
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
umuetduhwghjjls
10 Nov 21
Spanish Regulator Grants Enlivex Authorization to Expand its Phase IIb Trial Evaluating Allocetra in Severe and Critical COVID-19 Patients into Spain
8:00am
6-K
EX-99.1
a68sflps ofkik
4 Nov 21
Spanish Regulator Grants Enlivex Authorization To Expand Its Sepsis Phase II into Spain
8:01am
6-K
EX-99.1
77f1vmjq08euayhf183
5 Oct 21
Enlivex Receives Notice of Allowance for Israeli Patent Application
8:01am
6-K
EX-99.1
37rfdln
4 Oct 21
Report of Foreign Private Issuer
8:00am
6-K
EX-99.1
dkbhirgcuvr5 omjmtb
22 Sep 21
Report of Foreign Private Issuer
6:02am
6-K
EX-99.1
o9msyf lrnky7ongut
16 Aug 21
Report of Foreign Private Issuer
6:12am
6-K
EX-99.1
6u689tw02fo26qri
9 Aug 21
Enlivex Announces Second Quarter 2021 Financial Results and Provides a Business Update
8:00am
6-K
EX-99.2
m8mfmngmk3 ukz6jxso
6 Aug 21
Condensed Consolidated Financial Statements
4:31pm
6-K
EX-99.1
4cc3ed
2 Aug 21
Enlivex Hires Biotech Industry Veteran Tzvi Palash to Lead the Design and Construction of its New cGMP Allocetra Manufacturing Plant
8:02am
6-K
EX-99.1
p0kly1ji1ifhdzun52
12 Jul 21
Enlivex Initiates Design and Construction Process for a New cGMP Allocetra Manufacturing Plant
8:00am
6-K
EX-99.1
g39nnypq6ol70vjroj
15 Jun 21
Report of Foreign Private Issuer
7:55am
S-8
zbpyzxm
4 Jun 21
Registration of securities for employees
4:16pm
6-K
EX-99.1
9q0fonbmv41lk
1 Jun 21
Enlivex Announces Issuance of New Canadian Patent Covering Pharmaceutical Compositions, Manufacturing Methods and Uses of Allocetra Immunotherapy
8:02am